Bronchoscopic coil treatment for patients with severe emphysema: A meta-analysis

Respiration

Volumn 90, Issue 2, 2015, Pages 136-145

  Slebos, Dirk Jan ^a   Hartman, Jorine E ^a   Klooster, Karin ^a   Blaas, Stefan ^b   Deslee, Gaetan ⁱ   Gesierich, Wolfgang ^c   Hetzel, Juergen ^d   Hetzel, Martin ^e   Mcnulty, William ^l,m   Kemp, Samuel V ^l,m   Kessler, Romain ^j   Leroy, Sylvie ^k   Stanzel, Franz ^f   Witt, Christian ^g   Zoumot, Zaid ^l,m,n   Herth, Felix J F ^h   Shah, Pallav L ^l,m  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Donaustauf Hospital   (Germany)

^c ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e Krankenhaus vom Roten Kreuz   (Germany)

^f LUNGENKLINIK HEMER   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ REIMS UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^k UNIVERSITY HOSPITAL OF NICE   (France)

^l ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^m CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

ⁿ HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

more..

Author keywords

Bronchoscopic lung volume reduction; Chronic obstructive pulmonary disease; Emphysema

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HUMAN; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PATIENT SAFETY; PNEUMONIA; PNEUMOTHORAX; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; RESIDUAL VOLUME; ST. GEORGE RESPIRATORY QUESTIONNAIRE; THERAPY EFFECT; THORAX PAIN; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; WALKING; ADVERSE EFFECTS; AGED; COMPLICATION; LUNG FUNCTION TEST; LUNG RESECTION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PSYCHOLOGY; PULMONARY EMPHYSEMA;

AGED; BRONCHOSCOPY; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 84942199189     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000431384     Document Type: Article

References (24)

1. Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis. 2010; 4: 225-231.
2. Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest. 2012; 142: 574-582.
3. Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005; 2: 111-124.
4. Hartman JE, Ten Hacken NH, Klooster K, Boezen HM, de Greef MH, Slebos DJ. The minimal important difference for residual volume in patients with severe emphysema. Eur Respir J. 2012; 40: 1137-1141.
5. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F; National Emphysema Treatment Trial (NETT) Research Group: The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011; 37: 784-790.
6. Jones PW. St Georges Respiratory Questionnaire: MCID. COPD. 2005; 2: 75-79.
7. Shah P, Zoumot Z, Bicknell S, Ross E, Quiring J, Hopkinson N, Kemp S. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2013; 1: 233-240.
8. Deslee G, Klooster K, Hetzel M, Stanzel F, Kessler R, Marquette CH, Witt C, Blaas S, Gesierich W, Herth FJ, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014; 69: 980-986.
9. Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration. 2014; 88: 116-125.
10. Zoumot Z, Kemp SV, Singh S, Bicknell SR, McNulty WH, Hopkinson NS, Ross ET, Shah PL. Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLoS One. 2015; 10: e0122656.
11. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54: 581-586.
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-338.
13. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26: 511-522.
14. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111-117.
15. Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St Georges Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145: 1321-1327.
16. Mineshita M, Slebos DJ. Bronchoscopic interventions for chronic obstructive pulmonary disease. Respirology. 2014; 19: 1126-1137.
17. Shah PL, Herth FJ. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax. 2014; 69: 280-286.
18. Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest. 2012; 142: 1111-1117.
19. Snell G, Herth FJ, Hopkins P, Baker KM, Witt C, Gotfried MH, Valipour A, Wagner M, Stanzel F, Egan JJ, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J. 2012; 39: 1326-1333.
20. Shah PL, Slebos DJ, Cardoso PF, Cetti E, Voelker K, Levine B, Russell ME, Goldin J, Brown M, Cooper JD, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet. 2011; 378: 997-1005.
21. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187: 347-365.
22. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE; National Emphysema Treatment Trial Research Group: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348: 2059-2073.
23. Hartman JE, Klooster K, Gortzak K, Ten Hacken NH, Slebos DJ. Long-Term followup after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology. 2015; 20: 319-326.
24. Deslee G, Barbe C, Bourdin A, Durand-Zaleski I, Dutau H, Jolly D, Jounieaux V, Kessler R, Mal H, Pison C, et al. Cost-effectiveness of lung volume reduction coil treatment in emphysema. STIC REVOLENS (in French). Rev Mal Respir. 2012; 29: 1157-1164.